US Executive Compensation Proxy SEC Filings — April 16, 2026

16-04-2026

Stellus Private Credit BDC shareholders are voting on a new investment advisory agreement with Stellus Private BDC Advisor, LLC, identical to the existing one, to ensure continuity following Ridgepost Capital, LLC's acquisition of Stellus Capital Management, LLC (announced February 5, 2026), which controls the Advisor. The transaction promises enhanced resources from Ridgepost's $43.0B AUM, including better investor relations, deal sourcing, and IT capabilities, with all current investment professionals retained. Proxy solicitation costs are split evenly between Stellus Capital Management and Ridgepost, including an estimated $21,700 fee to Alliance Advisors LLC.

• ·Filing date: April 16, 2026
• ·Advisor Change in Control announcement: February 5, 2026; expected closing mid-2026
• ·Existing Investment Advisory Agreement dated January 7, 2022; renewed most recently January 7, 2026
• ·Base management fee waived in full until September 30, 2024; excess over 1.00% waived until Common Shares listing
• ·Income-based incentive fee includes 100% catch-up above 1.5% quarterly hurdle until 10% (pre-listing) or 15% (post-listing) of Pre-Incentive Fee Net Investment Income
• ·Capital gains incentive fee: 10% (pre-listing) or 15% (post-listing) of cumulative net realized gains and unrealized appreciation

16-04-2026

Cohen & Company Inc. has issued its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders, to be held virtually on June 3, 2026 at 10:00 a.m. ET, with a record date of April 9, 2026. Stockholders will vote on electing five directors (Daniel G. Cohen, G. Steven Dawson, Jack J. DiMaio, Jr., Jack Haraburda, and Diana Louise Liberto), approving Amendment No. 4 to the 2020 Long-Term Incentive Plan to increase authorized common shares from 2,500,000 to 4,500,000 plus an annual 9% evergreen provision through 2030, and ratifying Grant Thornton LLP as auditors for the year ending December 31, 2026. As of the record date, 2,477,655 common shares, 4,983,557 Series E Preferred shares, and 22,429,541 Series F Preferred shares are outstanding, with voting rights of one vote per common share or per ten preferred shares.

• ·Voting: one vote per common share; one vote per every ten Series E or Series F Preferred shares.
• ·Quorum requires majority of votes entitled to be cast.
• ·Proposal 1 (director election) approved by plurality; Proposals 2 and 3 by majority of votes cast.
• ·Board has contractual obligation to nominate Daniel G. Cohen.
• ·Meeting access: www.virtualshareholdermeeting.com/COHN2026 with 16-digit control number.

16-04-2026

Vireo Growth Inc.'s DEF 14A proxy statement details 2025 non-employee director compensation, including an annual cash retainer of $71,000, RSUs valued at $22,098 (44,643 units), and option awards valued at $21,883 (53,052 options), totaling $114,981 for Ross M. Hussey, Victor E. Mancebo, and Judd T. Nordquist; Kyle Kingsley received $260,000 base salary as Co-Executive Chair. The filing outlines insider trading policies, shareholder communication procedures, and executive compensation governance under the NCGC Committee, identifying named executives John Mazarakis (Co-Executive Chairman and CEO), Tyson Macdonald (CFO), and Sean Apfelbaum (General Counsel and Corporate Secretary). No period-over-period comparisons or performance metrics are provided.

• ·Non-employee directors held 44,643 unvested RSUs at December 31, 2025, vesting ratably on first three anniversaries of January 17, 2025 grant date until January 17, 2028.
• ·Company options for non-employee directors vest in full on January 17, 2026.
• ·Proxy statement filed April 16, 2026, references Annual Report on Form 10-K for fiscal year ended December 31, 2025, filed March 17, 2026.
• ·NCGC Committee approves equity awards under 2019 Incentive Plan; no stock options issued to executives in 2025 during blackout periods post-material disclosures.

16-04-2026

Immunocore Holdings plc has filed its DEF 14A proxy statement for the 2026 Annual General Meeting (AGM) on May 27, 2026, at 2:00 p.m. London time, held hybrid in London and via meetnow.global/IHCAGM2026, seeking shareholder approval via ordinary resolutions for re-appointing directors Siddharth Kaul, William Pao M.D. Ph.D., and Kristine Peterson; advisory vote on named executive officer compensation; ratification and re-appointment of Deloitte LLP as U.S. and U.K. auditors; adoption of the 2025 U.K. annual report and directors' remuneration report; and authorization for political donations/expenditures up to £50,000 each to parties, organizations, or incurred directly. The board recommends voting in favor of all resolutions, with voting by poll and record date of May 22, 2026 at 6:00 p.m. London time for ordinary shares.

• ·Ordinary share record date for AGM voting: May 22, 2026, 6:00 p.m. London time (1:00 p.m. EDT)
• ·ADS holder record date: April 2, 2026, 5:00 p.m. EDT
• ·Proxy submission deadline: May 22, 2026, 2:00 p.m. London time (9:00 a.m. EDT)
• ·Political donation/expenditure authority period: from AGM to 2027 AGM or May 27, 2027, whichever later

16-04-2026

Mechanics Bancorp's proxy statement for the 2026 Annual Meeting on May 28, 2026, seeks shareholder approval for electing eight directors, an advisory vote on named executive officer compensation, and ratification of Crowe LLP as independent auditors for the year ending December 31, 2026. It details the September 2, 2025 merger with Mechanics Bank, under which 200,901,384 Class A shares and 1,114,448 Class B shares were issued to Mechanics Bank shareholders, resulting in them owning 91.7% of the economic interest and 91.3% of voting power, while legacy shareholders hold 8.3% economic and 8.7% voting interest. Post-merger, Ford Entities control 77.7% of voting power, making the company a controlled company under Nasdaq rules, with the board reconstituted primarily from Mechanics Bank directors plus one legacy director.

• ·Record Date: April 1, 2026
• ·Annual Meeting: May 28, 2026, 9:00 a.m. Pacific Time, at 1111 Civic Drive, Suite 390, Walnut Creek, California 94596, and virtually at www.virtualshareholdermeeting.com/MCHB2026
• ·In-person preregistration deadline: 5:00 p.m. Pacific Time on May 21, 2026
• ·Merger exchange ratios: 3,301.0920 Class A shares per Mechanics Bank voting common share; 330.1092 Class B shares per Mechanics Bank non-voting common share

16-04-2026

Smith Micro Software, Inc. has filed a definitive proxy statement for its 2026 Annual Meeting on May 26, 2026, virtually at meetnow.global/MCVKKST, seeking stockholder approval for electing two directors, an advisory 'say on pay' vote on 2025 named executive officer compensation, ratification of SingerLewak LLP as auditor, amendment to the Omnibus Equity Incentive Plan for additional shares, Nasdaq-compliant approvals for potentially dilutive share issuances from 2025 warrants exceeding 20% of outstanding common stock, a reverse stock split from 1:3 to 1:10, and adjournment if needed. These proposals highlight efforts to maintain Nasdaq compliance amid warrant exercises and address equity incentives, but the reverse stock split and dilutive issuances signal potential share price pressures and dilution risks for existing shareholders. The record date is April 2, 2026, with a 40% quorum requirement.

• ·Reverse stock split ratio to be determined by Board between 1:3 and 1:10
• ·Nasdaq Proposal I relates to note purchase agreements dated September 11, 2025 and September 29, 2025
• ·Nasdaq Proposal II relates to private placement securities purchase agreement dated November 5, 2025
• ·Proxy materials available at www.envisionreports.com/SMSI

16-04-2026

OP Bancorp issued its definitive proxy statement for the 2026 Annual Meeting of Shareholders on May 28, 2026, seeking approval to elect 7 directors for one-year terms expiring in 2027, an advisory vote on 2025 named executive officer compensation, and ratification of Crowe LLP as independent auditors for the year ending December 31, 2026. The record date is April 2, 2026, with 14,894,239 shares of common stock outstanding, entitling record holders to one vote per share (cumulative for directors). Proxy materials are available online, with voting options via internet, phone, or mail.

• ·Annual Meeting location: 1000 Wilshire Boulevard, Suite 500, Los Angeles, California 90017.
• ·Shareholders planning to attend in person must notify by May 15, 2026 via phone (213) 892-9999, email IRSupport@myopenbank.com, or mail.
• ·Cumulative voting permitted for director election (Proposal 1).

16-04-2026

Arbor Realty Trust's DEF 14A proxy statement outlines the annual meeting agenda, including election of four Class II directors—Ivan Kaufman, Melvin F. Lazar, Dr. Carrie Wilkens, and John Natalone—for terms until 2029, amendment to the Stock Incentive Plan authorizing 8,000,000 additional shares, ratification of Ernst & Young as auditors for 2026, and an advisory vote approving NEO compensation. The Board comprises 10 members across three classes, with no financial performance metrics or period comparisons disclosed in the provided content. No declines or flat performances noted.

• ·Class II director nominees ages: Ivan Kaufman (65), Melvin F. Lazar (87), Carrie Wilkens (56), John Natalone (60)
• ·Class I directors terms expire 2028: Caryn Effron (64), Edward Farrell (65), George Tsunis (58)
• ·Class III directors terms expire 2027: Kenneth J. Bacon (71), William C. Green (65), Elliot Schwartz (65)
• ·Melvin F. Lazar stepping down as Chair of the Audit Committee as of December 31, 2025
• ·Filing date: April 16, 2026; annual meeting table of contents to be filed within four business days post-meeting

16-04-2026

Excelerate Energy, Inc. issued its definitive proxy statement for the 2026 Annual Meeting of Stockholders, to be held virtually on June 4, 2026 at 9:00 AM Central Time via www.proxydocs.com/EE, with a record date of April 7, 2026. Proposals include electing seven director nominees for one-year terms (Proposal 1), approving on a non-binding advisory basis the 2025 compensation of named executive officers (Say-on-Pay, Proposal 2), and ratifying PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026 (Proposal 3). The board unanimously recommends voting 'FOR' all proposals; no financial performance declines or flat metrics are highlighted in the provided content.

• ·Proxy materials made available on or about April 16, 2026 via 'notice and access' model
• ·Meeting check-in begins at 8:54 AM Central Time on June 4, 2026; technical support at 888-491-1002
• ·Board committees: Audit (AC), Compensation (CC), Nominating and Corporate Governance (NCGC); Deborah L. Byers and Paul T. Hanrahan noted as Audit Committee Financial Experts
• ·Fiscal 2025 highlights reference Adjusted EBITDA (non-GAAP) and Net Debt as of December 31, 2025 (reconciliation in Form 10-K)

16-04-2026

Four Corners Property Trust, Inc.'s DEF 14A proxy statement for the 2026 Annual Meeting details the director compensation policy, including a $70,000 base cash retainer and $125,000 in RSUs for non-employee directors (with Douglas B. Hansen receiving $185,000 in RSUs), and reports 2025 company performance highlights such as $325.5 million in real estate investments across 105 properties, FFO of $1.68 per diluted share (up $0.03 YoY), AFFO of $1.78 per diluted share (up $0.05 YoY), and a 3.2% dividend increase to $1.4660 per share. Non-employee directors earned total compensation ranging from $192,857 to $285,714 in 2025, with all complying with the $400,000 stock ownership policy. Shareholders approved the executive compensation program with 98.5% support.

• ·Credit facility increased from $765M to $940M, with revolving capacity to $350M and new $225M term loan.
• ·John S. Moody left the Board in March 2025 and received $49,602 in cash fees with no stock awards.
• ·Unvested RSUs as of Dec 31, 2025: Hansen 7,002; others 4,731 each.
• ·Five directors elected to defer receipt of 2025 RSU shares; none elected cash retainers in RSUs.

16-04-2026

First Interstate BancSystem, Inc. filed its 2026 Proxy Statement for the Annual Meeting on May 27, 2026, seeking shareholder approval to elect three directors, amend the Charter for plurality voting in contested elections, approve NEO compensation on an advisory basis, and ratify Ernst & Young LLP as auditors for 2026. 2025 financial highlights include net income of $302.1 million, diluted EPS of $2.94, ROAE of 8.83%, ROATCE of 13.53%, BVPS of $34.09, TBVPS of $22.40, and shareholder returns of $311.9 million (103% of net income) via $1.88 per share dividends and $117.6 million in share repurchases (3,653,914 shares at $32.18 average). Strategic progress featured branch optimizations (sales/closures in AZ, KS, NE, MN, ND), outsourcing consumer credit cards, discontinuing indirect loans, reducing borrowed funds from $1.6 billion to zero, and expanding NIM sequentially with cost of funds declining to 1.47% from 1.83% in 2024.

• ·Record date: April 2, 2026
• ·Annual meeting location: First Interstate Center, 401 N. 31st Street, Billings, Montana 59101 at 4:00 p.m. MT
• ·Completed sale of Arizona and Kansas branches in 2025; 11 Nebraska branches closed April 2026; six branches closed February 2026 in Minnesota, Nebraska, North Dakota
• ·Outsourced consumer credit card portfolio and discontinued originating indirect loans in 2025

16-04-2026

Valued Advisers Trust is holding a special shareholder meeting on May 8, 2026, for the LS Opportunity Fund to approve a sub-advisory agreement between Long Short Advisors, LLC (Adviser) and Grantham, Mayo, Van Otterloo & Co. LLC (Sub-Adviser), and to authorize reliance on a Manager of Managers order; the Board unanimously recommends voting FOR both proposals following their approval on March 23-24, 2026. The Sub-Adviser, with over $82 billion in assets under management as of February 28, 2026, will receive 50% of the 1.75% total advisory fee up to $200M in assets (shifting to 52% above), at the Adviser's expense. No performance declines or flat metrics are noted in the filing.

• ·Record date: March 25, 2026
• ·Sub-Advisory Agreement initial term: two years, with annual renewals subject to Board and shareholder approval
• ·Adviser location: 3330 Fairchild Gardens Avenue, Suite 30428, Palm Beach Gardens, FL 33420
• ·Sub-Adviser location: 53 State Street, Suite 3300, Boston, Massachusetts 02109
• ·Fund offices: 225 Pictoria Dr., Suite 450, Cincinnati, OH 45246
• ·Exclusivity arrangement: Sub-Adviser commits to exclusivity with Adviser for similar pooled investment vehicles
• ·Proxy materials available at: vote.proxyonline.com/vat/docs/LS2026mtg.pdf
• ·Voting hotline: (800) 859-8511 (Mon-Fri, 9:00 a.m. to 10:00 p.m. ET)

16-04-2026

Meta Platforms, Inc.'s 2026 Proxy Statement proposes the election of 12 director nominees with diverse expertise and ratification of Ernst & Young LLP as independent auditors for fiscal 2026, while recommending against all 9 shareholder proposals on topics including AI data usage, executive pay frequency, dual-class structure, human rights, antisemitism, climate commitments, and child safety in compensation. The company highlights engagement with over 50 shareholders representing approximately 40% of outstanding shares and an executive compensation program heavily weighted toward equity awards, with the CEO receiving a $1 annual base salary. No declines or flat metrics are reported, as this is a governance-focused filing.

• ·Shareholder engagement in 2025 covered corporate governance, board of directors, AI, platform integrity, youth safety, and sustainability.
• ·Board voting recommendations: FOR Proposal 1 (election of 12 directors) and Proposal 2 (ratification of Ernst & Young LLP); AGAINST Proposals 3-11.
• ·Annual Meeting voting matters detailed on pages 24, 38, 67-81 of the proxy statement.
• ·Proxy statement filed April 16, 2026, covering fiscal year ending December 31, 2025.

16-04-2026

Rani Therapeutics Holdings, Inc. disclosed 2025 executive compensation in its DEF 14A proxy statement, including performance-based bonuses awarded at 75% of target for partial achievement of corporate goals such as financing, partnering, clinical studies, and organizational objectives, totaling $351,600 for CEO Talat Imran, $259,700 for CFO Svai Sanford, and $241,900 for CBO Kate McKinley. Executives received retention payments of $139,000 for Sanford and $130,000 for McKinley amid cash preservation efforts, including voluntary salary reductions, while significant equity grants were issued, such as 1,053,000 options to Imran at $0.62/share. The company met its $50,000,000 Financing Threshold in October 2025, restoring Imran's base salary to $625,100, with outstanding equity awards valued based on a December 31, 2025 closing stock price of $1.35.

• ·Stock option repricing to $2.84/share approved Dec 16, 2023 for certain unvested awards.
• ·All named executives eligible for annual bonuses targeting 75% of base salary based on corporate goals including licensing deals, capital raise, clinical study initiation, product development, and talent objectives.
• ·Equity awards under 2021 Plan and 2016 Equity Incentive Plan vest over 4 years with monthly or quarterly schedules.

16-04-2026

First Financial Bancorp's DEF 14A Proxy Statement for the May 26, 2026 virtual Annual Meeting seeks shareholder approval for electing 10 directors, ratifying Crowe LLP as 2026 independent auditors, approving the 2026 Stock Plan, and an advisory vote on executive compensation; record date is March 27, 2026. The company reports strong 2025 performance with record revenue and noninterest income, completion of Westfield Bank acquisition adding 8 financial centers in northeast Ohio, and an agreement to acquire BankFinancial Corporation. Community initiatives included $4.6 million in grants/donations and over 16,300 associate volunteer hours, with no material declines noted.

• ·Annual Meeting at 10:00 AM Eastern Time on May 26, 2026, virtually at virtualshareholdermeeting.com/FFBC2026
• ·Shareholders of record as of March 27, 2026 eligible to vote
• ·5-star rating from Bauer Financial; Investment Grade rating from Kroll Bond Rating Agency
• ·Received Gallup Exceptional Workplace Award and second consecutive Outstanding CRA rating from Federal Reserve Board

16-04-2026

Glaukos Corporation's DEF 14A Proxy Statement, filed April 16, 2026, solicits stockholder votes for the 2026 Annual Meeting on May 28, 2026, to elect two Class II directors until 2029, approve named executive officer compensation on an advisory basis, and ratify Ernst & Young LLP as independent auditors for 2026. The company highlights 2025 net sales of $507M and cash, equivalents, restricted cash, and short-term investments of $283M as of December 31, 2025, while operating in 17 countries with over 300 global commercial personnel. No period-over-period comparisons or performance declines are disclosed in the provided content.

• ·Record date: April 2, 2026
• ·Annual Meeting: May 28, 2026, 9:00 a.m. Pacific Time, virtual webcast at www.virtualshareholdermeeting.com/GKOS2026
• ·Proxy materials first available: on or about April 16, 2026

16-04-2026

Cathay General Bancorp (CATY) has issued its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders, to be held virtually on May 18, 2026 at 5:00 p.m. PT, with a record date of March 26, 2026. Stockholders are asked to elect four Class III directors (Nelson Chung, Felix S. Fernandez, Maan-Huei Hung, Richard Sun) to serve until 2029, approve executive compensation on an advisory basis, vote on holding future say-on-pay votes every year, and ratify KPMG LLP as the independent auditor for fiscal 2026. The Board recommends FOR all director nominees, FOR executive compensation, EVERY YEAR for frequency, and FOR auditor ratification; 66,972,039 shares of common stock were outstanding on the record date.

• ·Quorum requires majority of outstanding shares present in person or by proxy.
• ·Voting deadline via Internet/telephone: 11:59 p.m. ET on May 17, 2026.
• ·ESOPT shares voting instructions due by 11:59 p.m. ET on May 13, 2026.
• ·Proposals 1-3 are non-routine (broker non-votes possible); Proposal 4 is routine.
• ·Directors elected by majority of votes cast.

16-04-2026

Yum China Holdings, Inc.'s 2026 DEF 14A Proxy Statement details exceptional 2025 executive performance, driving 11% operating profit growth, 14% diluted EPS increase (excluding FX and mark-to-market equity investments impact of -$0.06), and 4% system sales growth (excluding FX). CEO Ms. Wat received a 2025 STI payout of $6,156,000 (216% of $2.85M target due to 180% team factor and 120% individual factor), with other NEOs receiving 210-244% of targets; 2025 LTI grants totaled $14.7M across NEOs, unchanged at $10M for the CEO. KFC and Pizza Hut achieved 5% and 4% system sales growth (ex-FX), 8% and 19% operating profit growth, respectively, with strong store expansion and delivery sales up 26% and 22% YoY.

• ·Pizza Hut OP margin reached 7.9% in 2025, highest since 2016 listing
• ·Company average commodity inflation 0.97x relative to China CPI Food Index from 2023-2025
• ·Mark-to-market equity investments impacted diluted EPS by -$0.06 in 2025 vs +$0.08 in 2024
• ·KFC delivery sales contributed 48% of Company sales; Pizza Hut 47% in 2025

16-04-2026

U.S. Physical Therapy, Inc. (USPH) has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders on May 19, 2026, proposing the election of seven directors, including new nominee Peter F. Minan to replace retiring directors Nancy J. Ham and Clayton K. Trier, with no reported controversies. Stockholders will also consider an advisory vote to approve named executive officer compensation and ratification of Grant Thornton LLP as independent auditors for the year ending December 31, 2026. The record date is March 25, 2026, and the Board recommends voting in favor of all proposals.

• ·Annual Meeting location: 1300 West Sam Houston Parkway South, Suite 300, Houston, Texas 77042 at 9:00 a.m. Central Time
• ·Record date: March 25, 2026
• ·Director ages: Christopher J. Reading (62), Kathleen A. Gilmartin (74), Dr. Bernard A. Harris, Jr. (69), Anne B. Motsenbocker (64), Regg E. Swanson (72), Michael G. Mayrsohn (39), Peter F. Minan (64)
• ·Proxy materials available at http://materials.proxyvote.com/90337L

16-04-2026

Korro Bio, Inc. (KRRO) filed its DEF 14A definitive proxy statement on April 16, 2026, for the virtual 2026 Annual Meeting of Stockholders on June 10, 2026, at 8:30 a.m. ET, with a record date of April 13, 2026. Proposals include election of Class I directors Nessan Bermingham and Rachel Meyers for three-year terms, a non-binding advisory vote to approve named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor for the fiscal year ending December 31, 2026. No financial performance metrics or period-over-period comparisons are detailed in the filing.

• ·Virtual meeting registration deadline: June 9, 2026, at 5:00 p.m. ET at www.proxydocs.com/KRRO.
• ·Notice of Availability mailed on or about April 20, 2026.
• ·Company address: 60 First Street, 2nd Floor, Suite 250, Cambridge, MA 02141.
• ·References 2025 Annual Report (Form 10-K for fiscal year ended December 31, 2025) available online.

16-04-2026

Net Lease Office Properties (NLOP) has issued a proxy statement for its virtual annual shareholder meeting on June 12, 2026, seeking approval to elect two Class II trustees (John J. Park and Richard J. Pinola) for a one-year term, authorize the Board to terminate the company after selling all or substantially all of its remaining 18 properties (down from an original portfolio of 59), and ratify PricewaterhouseCoopers LLP as auditor for 2026. The company, spun off from W. P. Carey Inc. in November 2023, continues its plan of strategic asset dispositions with immaterial indebtedness and expects to make periodic distributions from sale proceeds prior to any termination. While progress has been made in reducing the portfolio, the timeline for full liquidation remains uncertain due to market factors.

• ·Record date for voting: April 13, 2026
• ·Annual meeting: June 12, 2026 at 10:00 a.m. Eastern Time, virtual-only at www.virtualshareholdermeeting.com/NLOP2026
• ·NLOP formed October 21, 2022; Spin-Off completed November 1, 2023
• ·Termination requires two-thirds shareholder approval; abstentions and broker non-votes count as against
• ·Board to declassify in 2027; no shareholder rights plan; opted out of Maryland Unsolicited Takeover Act

16-04-2026

PAR Technology Corporation's DEF 14A proxy statement solicits votes for the 2026 Annual Meeting on May 29, 2026, including election of seven directors by plurality vote, approval of the Amended 2015 Equity Incentive Plan by majority of votes cast, a non-binding say-on-pay advisory vote, and ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026. As of the record date April 8, 2026, 41,246,199 shares of common stock were outstanding, each entitled to one vote. No financial performance or compensation metrics are provided in the extracted content.

• ·Annual Meeting: May 29, 2026, at 10:00 a.m. Eastern Time, virtually at www.virtualshareholdermeeting.com/PAR2026
• ·Record date: April 8, 2026
• ·Voting deadline for internet/telephone: 11:59 p.m. ET on May 28, 2026
• ·Quorum: majority of voting power of outstanding capital stock
• ·Proposal 4 is routine (broker discretionary voting allowed)

16-04-2026

ACV Auctions Inc. filed its DEF 14A Proxy Statement for the 2026 Annual Meeting on May 27, 2026, seeking shareholder approval for electing two Class II directors (Brian Hirsch and Eileen Kamerick), an advisory vote on named executive officer compensation, and ratification of Ernst & Young LLP as independent auditors. The company highlighted strong FY2025 performance with total revenue of $760M (19% YoY increase), marketplace and service revenue of $678M (18% YoY increase), and 829,276 marketplace units (12% YoY increase), with no declines or flat metrics reported.

• ·Annual Meeting: May 27, 2026 at 4:00 p.m. ET, virtual at www.proxydocs.com/ACVA; Record Date: April 1, 2026; Notice mailed on or about April 16, 2026.
• ·Board consists of seven members divided into three classes; Class II nominees for three-year terms.
• ·Proxy materials available at www.proxydocs.com/ACVA and investors.acvauto.com.

16-04-2026

Gogo Inc. filed its DEF 14A proxy statement on April 16, 2026, for the 2026 Annual Meeting of Stockholders, to be held online on May 28, 2026, at 9:00 a.m. Mountain Time, with a record date of April 6, 2026. Key proposals include election of three Class I directors, an advisory vote approving 2025 executive compensation, approval of the Amended and Restated 2024 Omnibus Equity Incentive Plan, and ratification of Deloitte & Touche LLP as independent auditors; the board recommends voting FOR all items. Proxy materials, including the 2025 Annual Report, are available online at www.proxydocs.com/GOGO.

• ·Meeting attendance limited to stockholders of record as of April 6, 2026, valid proxy holders, and invited guests
• ·XBRL tags reference compensation elements for PEO (Oakleigh Thorne, Chris Moore) and Non-PEO NEOs across 2021-2025, including equity awards, fair value changes, and vesting details

16-04-2026

Spectral AI, Inc. has filed a proxy statement for its 2026 Annual Meeting of Stockholders on May 29, 2026, at 9:30 a.m. CDT (hybrid in-person at Dallas headquarters and virtual), to elect five directors, ratify Forvis Mazars, LLP as independent auditors for fiscal 2026, and authorize share issuance to Hudson Bay Master Fund Ltd. under the October 24, 2025 Securities Purchase Agreement for Nasdaq compliance. The record date is April 1, 2026, with 31,823,985 shares of Common Stock outstanding entitled to vote. No financial performance metrics or period comparisons are detailed in the filing.

• ·Annual Meeting quorum requires majority voting power of outstanding shares present in person, by proxy, or remote communication.
• ·Voting deadline for internet/telephone: 9:29 a.m. CDT on May 29, 2026; questions submission deadline: 10:59 p.m. CDT on May 28, 2026.
• ·Nasdaq Marketplace Rule referenced: 5635(b) in notice, 5635(d) in proposal details.
• ·Form 10-K for fiscal year ended December 31, 2025 filed with SEC on March 25, 2026.

16-04-2026

Roblox Corporation's 2026 Proxy Statement features a letter from CEO David Baszucki highlighting FY2025's strong performance, including revenue growth of 36% YoY to $4.9B, bookings growth of 55% YoY to $6.8B, DAUs reaching 144M in Q4 2025 (up ~60M YoY), and creators earning over $1.5B. The annual meeting on May 28, 2026, proposes election of Class II directors, advisory approval of NEO compensation, and ratification of the independent auditors. Advancements in AI (400+ models trained on 12B hours of monthly data) and safety measures like mandatory age-checks support long-term growth vision with no reported declines.

• ·Annual Meeting: May 28, 2026 at 8:00 a.m. PT virtually
• ·Record date: April 1, 2026
• ·Proposals: (1) Election of Class II Directors, (2) Advisory vote on NEO compensation, (3) Ratification of independent auditors

16-04-2026

Upstart Holdings, Inc. (UPST) filed a DEF 14A proxy statement dated April 16, 2026, for its 2026 Annual Meeting, proposing the election of Kerry Cooper, Mary Hentges, and Ciaran O’Kelly as Class III directors to serve until the 2029 annual meeting, ratification of Deloitte & Touche LLP as independent auditors for the fiscal year ending December 31, 2026, and advisory approval of named executive officer compensation. The record date is March 31, 2026, with 95,707,260 shares of common stock outstanding entitled to vote, and the Board recommends voting 'FOR' all proposals. Voting must be completed by 8:59 p.m. PT on May 27, 2026, with the virtual meeting accessible at www.virtualshareholdermeeting.com/UPST2026.

• ·Quorum requires presence of stockholders entitled to cast a majority of all issued and outstanding shares.
• ·Proxy holders: Paul Gu, Sanjay Datta, and Scott Darling.
• ·Transfer agent contact: Equiniti Trust Company, LLC, 1-800-937-5449 or helpAST@equiniti.com.

16-04-2026

Hertz Global Holdings, Inc.'s 2026 Proxy Statement seeks shareholder ratification of Ernst & Young LLP as independent auditor for the fiscal year ending December 31, 2026, and an advisory 'Say-on-Pay' vote approving 2025 named executive officer compensation. The Audit Committee, comprising independent directors including two financial experts, met eight times in 2025 to oversee financial reporting, internal controls, auditor independence, and compliance. The Board recommends voting FOR both proposals.

• ·Audit Committee selected EY as independent auditor for fiscal year ending December 31, 2025.
• ·Katherine Lee Martin resigned August 15, 2025.
• ·Christopher G. Berg commenced EVP Fleet Management role on March 6, 2026.
• ·Michael S. Moore commenced EVP COO role effective October 1, 2025.

16-04-2026

Upstream Bio, Inc. (UPB) filed a DEF 14A proxy statement dated April 16, 2026, for the election of two Class II directors, H. Edward Fleming, Jr., M.D. (age 63, director since 2023) and Liam Ratcliffe, M.B.Ch.B., Ph.D., M.B.A. (age 62, director since 2021), whose terms expire at the upcoming Annual Meeting. The board of seven directors is divided into three classes with staggered three-year terms: Class I (expiring 2028), Class II (expiring 2026, nominees), and Class III (expiring 2027). The board recommends voting FOR both nominees, with plurality vote required and no financial metrics or performance changes disclosed.

• ·Board directors removal requires 2/3 affirmative vote of voting power for cause only.
• ·Vacancies filled by majority of directors then in office, even if less than quorum.
• ·Ages as of April 13, 2026: Nominees 63 and 62; Continuing directors 56, 57, 47, 62, 63.
• ·Company intends to file Form 8-K with voting results within four business days post-Annual Meeting.
• ·Nominees' terms, if elected, end at 2029 annual meeting.

16-04-2026

Life360's 2026 proxy statement for the May 28 annual meeting summarizes strong 2025 performance, including revenue of $489.5 million (32% YoY growth), 95.8 million monthly active users, 2.8 million Paying Circles (26% growth), first full year of positive net income exceeding $32 million, and Adjusted EBITDA of $93.2 million with margin expansion from 12% in 2024 to 19%. The company highlights the Nativo acquisition, Pet GPS launch in five markets, and no material declines or flat metrics. Executive letters from Chairman Chris Hulls and CEO Lauren Antonoff emphasize strategic priorities in audience growth, paid offerings, new revenue streams, and profitability.

• ·Annual meeting: May 28, 2026 at 3:00 p.m. Pacific Time (virtual at www.virtualshareholdermeeting.com/LIF2026)
• ·Members drove 611 billion miles with crash detection active in 2025
• ·85 billion safe arrival notifications delivered in 2025
• ·Proposals: Election of directors, advisory vote on executive compensation, ratification of independent auditors

16-04-2026

Arista Networks' 2026 Proxy Statement seeks shareholder approval for the election of three director nominees (Lewis Chew, Greg Lavender, Mark B. Templeton), advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditors for fiscal year ending December 31, 2026. The board maintains a staggered structure with independent directors serving on key committees like Audit and Compensation, emphasizing strong corporate governance practices. Director biographies highlight extensive experience in technology, finance, and leadership from firms including Intel, Citrix, and Dolby Laboratories.

• ·Proposal 1 (Director Election): Plurality vote; abstentions and broker non-votes have no effect.
• ·Proposal 2 (NEO Compensation, advisory): Majority of votes present; abstentions count as AGAINST.
• ·Proposal 3 (Auditor Ratification): Majority of votes present; abstentions count as AGAINST.
• ·Board is divided into three staggered classes with three-year terms.
• ·Voting results to be filed via Form 8-K within four business days post-Annual Meeting.

16-04-2026

Docusign's FY2026 proxy statement highlights strong revenue growth of 8% YoY to $3.2B and ARR to $3,272M, with customer base expanding to over 1.8 million, alongside Non-GAAP diluted EPS increasing to $3.84 from $3.55. However, GAAP net income per diluted share declined sharply to $1.48 from $5.08, and Non-GAAP gross margin dipped slightly to 82.0% from 82.2%. The Board proposes director elections, auditor ratification, Say-on-Pay votes, and plans board declassification starting 2028, while addressing stockholder feedback on compensation.

• ·Annual Meeting scheduled for June 1, 2026 at 9:00 a.m. PT virtually; record date April 7, 2026.
• ·Board nominees for election until 2029 Annual Meeting: James Beer, Cain A. Hayes, Allan Thygesen.
• ·Plans to seek stockholder approval in 2027 for board declassification, transitioning to annual elections by 2030.
• ·Stockholder proposal (Proposal 05) on risks of non-fiduciary executive compensation metrics; Board recommends AGAINST.

16-04-2026

Third Coast Bancshares, Inc. (TCBX) has filed a DEF 14A proxy statement for its 2026 Annual Meeting of Shareholders scheduled for May 21, 2026, at 10:00 a.m. CT. Shareholders will vote on electing four Class A directors (Bart O. Caraway, Clint Greenleaf, Tony Scavuzzo, Mary Stich) to serve until 2029 and one Class C director (Jeffrey A. Wilkinson) until 2028, approving the Amended and Restated 2019 Omnibus Incentive Plan, and ratifying Whitley Penn LLP as independent auditors for the year ending December 31, 2026. As of the record date March 27, 2026, 16,562,087 shares of common stock were outstanding.

• ·Annual meeting location: 20202 Highway 59 North, Suite 190, Humble, Texas 77338.
• ·Quorum requires majority of outstanding shares represented in person or by proxy.
• ·Board recommends FOR all three proposals; majority of votes cast needed for approval.
• ·Proxy materials available online at www.proxydocs.com/TCBX.

16-04-2026

Neurogene Inc. (NGNE) filed its DEF 14A Proxy Statement on April 16, 2026, for the virtual 2026 Annual Meeting of Stockholders on June 3, 2026, at 9:00 a.m. ET. Stockholders of record as of April 7, 2026 (15,615,786 shares outstanding) will vote on electing Robert Baffi, Ph.D. and Rohan Palekar as Class III directors until 2029, advisory approval of named executive officer compensation, ratification of Deloitte & Touche LLP as auditors for the year ending December 31, 2026, and the frequency of future say-on-pay votes.

• ·Annual Meeting accessible virtually at www.virtualshareholdermeeting.com/NGNE2026.
• ·Proxy materials available online at www.proxyvote.com and ir.neurogene.com.
• ·Company rebranded from Neoleukin Therapeutics, Inc. on December 18, 2023 following merger with Neurogene OpCo.

16-04-2026

Pharma-Bio Serv, Inc. will hold its Annual Meeting of Stockholders on May 15, 2026, at 10:00 a.m. local time in Boca Raton, FL, to elect Irving Wiesen as the Class I director for a term until the 2029 Annual Meeting and to ratify Crowe PR PSC as independent auditors for the fiscal year ending October 31, 2026. The record date is April 8, 2026, with 22,901,692 shares of common stock outstanding entitled to vote. No financial performance metrics or period-over-period comparisons are provided in the proxy statement.

• ·Board divided into three classes: Class I (Irving Wiesen, term expires 2026), Class II (Kirk Michel and Dov Perlysky, terms expire 2027), Class III (Howard Spindel, term expires 2028).
• ·Directors serve staggered three-year terms.
• ·Registration for in-person attendance required by May 8, 2026, via email to 2026annualmeeting@akerman.com.
• ·Annual Report on Form 10-K for fiscal year ended October 31, 2025, available at http://www.pharmabioserv.com.

16-04-2026

Colony Bankcorp, Inc. has filed its DEF 14A proxy statement for the 2026 Annual Meeting of Shareholders on May 21, 2026, at 11:00 a.m. local time in Fitzgerald, Georgia, seeking shareholder approval for the election of eight directors, an advisory vote on executive compensation, and ratification of Mauldin & Jenkins, LLC as independent auditors for the year ending December 31, 2026. The record date is March 27, 2026, with 21,172,315 shares of common stock outstanding, of which directors and executive officers hold 830,645 shares (approximately 3.92%). No financial performance metrics or period-over-period changes are disclosed in the filing.

• ·Annual Meeting location: Fitzgerald Utilities Building, 103 W Central Ave., Fitzgerald, Georgia 31750.
• ·Proxy materials available online at https://materials.proxyvote.com/19623P.
• ·Quorum requires majority of outstanding shares; director election by majority of votes cast (plurality if contested).

16-04-2026

Impinj, Inc. filed its DEF 14A definitive proxy statement on April 16, 2026, for the virtual annual meeting of stockholders on May 28, 2026, at 9:00 a.m. PT. Key votes include electing seven director nominees (Chris Diorio, Daniel Gibson, Umesh Padval, Steve Sanghi, Meera Rao, Arthur Valdez, Jr., and Miron Washington), ratifying Ernst & Young LLP as independent auditors for the year ending December 31, 2026, advisory approval of named executive officer compensation, and approval of the 2026 Equity Incentive Plan. The record date is April 8, 2026, with 30,459,059 shares of common stock outstanding.

• ·Annual meeting held virtually at www.virtualshareholdermeeting.com/PI2026.
• ·Proxy materials available at www.proxyvote.com; Notice mailed on or about April 16, 2026.
• ·Board recommends FOR all proposals.

16-04-2026

Esperion Therapeutics, Inc. filed its DEF 14A Proxy Statement on April 16, 2026, for the virtual 2026 Annual Meeting on May 28, 2026, seeking stockholder approval for electing two Class I directors (J. Martin Carroll and Sheldon L. Koenig), a non-binding advisory vote on named executive officer compensation, ratification of Ernst & Young LLP as auditors for the fiscal year ending December 31, 2026, and an amendment to increase authorized shares under the 2022 Stock Option and Incentive Plan by 7,000,000 shares. The Board unanimously recommends voting FOR all proposals. No financial performance metrics or period-over-period comparisons are detailed in the filing.

• ·Record Date: March 31, 2026
• ·Annual Meeting: Thursday, May 28, 2026, at 8:00 a.m. Eastern Time, virtually at www.virtualshareholdermeeting.com/ESPR2026
• ·Directors to serve until 2029 Annual Meeting

16-04-2026

Vince Holding Corp. is soliciting proxies for its 2026 Annual Meeting of Stockholders, to be held virtually on June 4, 2026, seeking approval to elect Michael Mardy as Class III director until 2029, ratify PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending January 30, 2027, approve executive compensation on an advisory basis, and amend the 2013 Omnibus Incentive Plan by increasing the share reserve by 1,000,000 shares. The record date is April 8, 2026, with 12,847,294 shares of common stock outstanding. No financial performance data or period-over-period comparisons are provided in the proxy statement.

• ·Annual Meeting accessible via live webcast at http://www.virtualshareholdermeeting.com/VNCE2026
• ·Fiscal 2024 ended February 1, 2025; Fiscal 2025 ended January 31, 2026
• ·P180 Vince Acquisition Co. acquired majority stake on January 22, 2025
• ·Asset Sale of VINCE intellectual property closed May 25, 2023

16-04-2026

Perspective Therapeutics, Inc. (CATX) filed its DEF 14A definitive proxy statement dated April 16, 2026, for the 2026 Annual Meeting of Stockholders on May 27, 2026, at 9:00 a.m. Central Time at the Sheraton Grand Chicago Riverwalk in Chicago, IL. Stockholders will vote on electing six directors (board recommends FOR all nominees), ratifying WithumSmith+Brown, PC as independent auditors for the fiscal year ending December 31, 2026 (FOR), and approving a 1-year frequency for advisory votes on executive compensation (1 YEAR). The record date is April 2, 2026, with proxy materials available online at www.proxyvote.com.

• ·Pre-registration for in-person attendance required by 5:00 p.m. Pacific Time on May 13, 2026
• ·Annual Report on Form 10-K for year ended December 31, 2025, available with proxy materials
• ·Meeting address: Sheraton Grand Chicago Riverwalk, 301 E North Water Street, Chicago, IL 60611

16-04-2026

Axon Enterprise, Inc. reported record 2025 revenue of $2.8 billion, up 33% YoY for the fourth consecutive year above 30%, driven by Software & Services growth over 40% to 43% of revenue and ARR of $1.3 billion with 125% net revenue retention. Adjusted EBITDA reached $710 million at a 25.5% margin while net income was $125 million at 4.5%, amid aggressive investments in AI and new products. The AI Era Plan booked approximately $750 million in its first full year, with progress on the Moonshot goal showing a nearly 10% decline in U.S. gun-related deaths from peak.

• ·TASER 10 cartridge fired approximately every 30 seconds in the U.S.
• ·Over 500 agencies live on Axon Assistant, supporting 50+ languages.
• ·Business realigned into connected hardware, software, and services as of January 1, 2025.
• ·Acquired Prepared and Carbyne to extend ecosystem to Axon 911.

16-04-2026

TerrAscend Corp. will hold its annual shareholder meeting virtually on June 9, 2026, at 1:00 p.m. ET to review audited financial statements for the fiscal year ended December 31, 2025, elect five directors, ratify MNP LLP as auditors for the fiscal year ending December 31, 2026, and approve unallocated stock options under the stock option plan and unallocated share units under the share unit plan. The record date is April 13, 2026, with proxies due by 1:00 p.m. ET on June 5, 2026. No period-over-period financial performance data is provided in the filing.

• ·Meeting held virtually at https://meetings.lumiconnect.com/400-346-948-510 (password: terrascend2026, case-sensitive)
• ·Mr. Stauffer resigned as Chief Financial Officer on July 18, 2025
• ·Mr. Ghanem promoted to President and Chief Executive Officer on March 29, 2023
• ·Ms. Gefen promoted to Chief People Officer on November 12, 2024, while retaining Chief Legal Officer and Corporate Secretary roles
• ·Proxy materials and Form 10-K for year ended December 31, 2025 available at https://ir.terrascend.com

16-04-2026

Valaris reported strong 2025 financial performance with net income of $979.1 million, Adjusted EBITDA of $642.2 million, cash from operations of $546.2 million, and Adjusted Free Cash Flow of $340.6 million, alongside fleetwide revenue efficiency of 96% for the fifth consecutive year. The company secured $2.6 billion in contract backlog during 2025 and an additional $900 million since early 2026, sold rigs for over $130 million in proceeds, and repurchased $100 million in shares. This proxy statement for the June 10, 2026 AGM seeks approval for director elections, NEO compensation, and KPMG as auditors, amid a pending all-stock acquisition by Transocean announced in February 2026.

• ·Annual General Meeting scheduled for June 10, 2026, at 8:00 a.m. Bermuda time in Hamilton, Bermuda.
• ·Record date for voting: April 13, 2026.
• ·Resolutions: (1) Election of six director nominees; (2) Advisory vote on NEO compensation; (3) Approval of KPMG LLP as independent auditor.
• ·Pending all-stock business combination with Transocean announced February 9, 2026, subject to shareholder and regulatory approvals; separate Scheme Meeting to be held.

16-04-2026

Kiniksa Pharmaceuticals International, plc (KNSA) has filed its DEF 14A proxy statement for the 2026 Annual Meeting of Shareholders on May 29, 2026, at 2:00 p.m. BST (9:00 a.m. EDT) in London, with a record date of April 6, 2026. Shareholders will vote on re-electing Class II Directors Stephen R. Biggar, G. Bradley Cole, and Barry D. Quart until the 2029 Annual Meeting; approving/ratifying PricewaterhouseCoopers LLP (PwC) as UK statutory auditors and US independent auditors; receiving the UK Annual Report for the year ended December 31, 2025; approving the UK Remuneration Report and Policy on advisory bases; and the Say-on-Pay vote for named executive officers. Corporate governance highlights include 9 out of 10 independent directors and robust compensation practices with no excessive perks or single-trigger equity acceleration.

• ·Annual Meeting location: Second Floor, 105 Piccadilly, London, United Kingdom W1J 7NJ
• ·Proposals include receipt of UK statutory annual accounts and reports for period ended December 31, 2025
• ·UK Remuneration Report and Policy set forth in Annex A

16-04-2026

Tenet Healthcare Corp's 2026 Proxy Statement seeks shareholder approval for the election of 12 director nominees (11 independent), an advisory vote on executive compensation, and ratification of Deloitte & Touche LLP as auditors for 2026. Business highlights include approximately 99,000 employees, 50 hospitals, 132 outpatient facilities, 533 ambulatory surgery centers, and 26 surgical hospitals as of December 31, 2025, with 2025 growth via a new 54-bed hospital, 6 de novo ASCs, 27 acquired ASCs, and 1 surgical hospital, supported by over $1B in capital expenditures. The company emphasizes strong governance with an independent Lead Director, board refreshment (6 new independents since 2018), and positive performance track record in net income, Adjusted EBITDA, EPS, and shareholder returns.

• ·2026 Annual Meeting: May 27, 2026 at 9:00 a.m. Central Time, virtual via www.proxydocs.com/THC; Record Date: April 2, 2026
• ·Board proposals: Vote FOR all 12 director nominees (majority vote standard), advisory approval of exec comp, ratification of Deloitte auditors
• ·Governance highlights: 11/12 independent directors, independent committee chairs, annual board self-evaluations, shareholder rights including proxy access and special meetings at 25% threshold
• ·Stephen Rusckowski appointed May 23, 2023 and resigned November 21, 2025

16-04-2026

Salesforce's 2026 DEF 14A Proxy Statement provides detailed biographies and qualifications for its eight directors, including long-tenured leaders like Marc Benioff (Director since 1999, age 61) and recent additions Amy Chang and David B. Kirk (both since 2025, ages 49 and 65). The board emphasizes expertise in AI, cloud computing, cybersecurity, global governance, and technology strategy, with key committees including Audit & Finance, Compensation, Nominating & Corporate Governance, and Cybersecurity & Privacy. The filing supports Proposal 1 for director elections at the upcoming Annual Meeting and includes XBRL tags for executive compensation disclosures covering fiscal periods like FY2026 (Feb 1, 2025 - Jan 31, 2026), though specific compensation values are not detailed in the provided content.

• ·Marc Benioff: Director since 1999; B.S. Business Administration, USC.
• ·Laura Alber: Director since 2021; Committees: Nominating & Corporate Governance.
• ·Amy Chang: Director since 2025; Committees: Nominating & Corporate Governance, Cybersecurity & Privacy.
• ·Craig Conway: Director since 2005; Committees: Audit & Finance, Business Transformation.
• ·Arnold Donald: Director since 2023; Committees: Audit & Finance, Nominating & Corporate Governance.
• ·Parker Harris: Director since 2018; Committees: Cybersecurity & Privacy.
• ·David B. Kirk: Director since 2025; Committees: Compensation, Cybersecurity & Privacy.
• ·Neelie Kroes: Director since 2016; Committees: Compensation, Cybersecurity & Privacy (Chair).
• ·No family relationships among directors or executive officers.
• ·XBRL compensation disclosures for PEO (e.g., Marc Benioff) and Non-PEO NEOs cover FY2022 to FY2026.

16-04-2026

FRP Holdings, Inc. filed its DEF 14A proxy statement dated April 16, 2026, for the virtual 2026 Annual Meeting of Shareholders on May 12, 2026 at 11:00 a.m. EDT, soliciting votes to elect nine director nominees for one-year terms, approve the 2026 Equity Incentive Plan, and approve on an advisory basis the compensation of named executive officers. The record date is March 16, 2026, with 19,171,625 shares of common stock outstanding; the board recommends voting 'FOR' all proposals. No financial performance metrics or period-over-period comparisons are detailed in the provided filing content.

• ·Annual meeting held virtually; access via www.frpdev.com > Investors > '2026 Annual Shareholders Meeting'
• ·To vote during virtual meeting, submit proof of ownership or proxy documentation to annualmeeting@frpdev.com prior to commencement
• ·Proxy statement first mailed to shareholders on or about April 28, 2026
• ·Director Election Proposal determined by plurality vote; Equity Incentive Plan and Compensation Proposal each require majority of votes cast

16-04-2026

Netflix's 2026 DEF 14A Proxy Statement details 2025 board governance, including 6 Board meetings with at least 75% attendance by all members and full attendance at most committee meetings (Compensation: 3, Audit: 7, Nominating & Governance: 4). Chairman Reed Hastings will not stand for re-election, leading to a review of leadership structure with co-CEOs Greg Peters and Ted Sarandos on the Board and Jay Hoag as lead independent director. Non-employee directors received stock option awards valued mostly at $407,877, with partial-year adjustments for Timothy M. Haley ($205,211), Elinor Mertz ($202,032), and Susan E. Rice ($373,592 options + $25,000 cash).

• ·Effective April 17, 2025, Reed Hastings transitioned from Executive Chairman to non-executive Chairman, receiving director compensation from May 2025.
• ·Leslie Kilgore moved from Audit Committee to Compensation Committee Chair on June 5, 2025.
• ·Elinor Mertz joined Audit Committee in June 2025.
• ·Ambassador Susan E. Rice transitioned from cash retainer to stock options in February 2025.
• ·Jay Hoag missed one Nominating and Governance Committee meeting convened to consider his resignation but attended all others.
• ·No Compensation Committee interlocks or insider participation.
• ·Director equity grants made monthly on first trading day at FMV strike price, fully vested upon grant.

16-04-2026

SEACOR Marine Holdings Inc. (SMHI) filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on June 2, 2026, at 9:00 a.m. EDT. Key agenda items include electing six directors, an advisory 'Say on Pay' vote on Named Executive Officer compensation, and ratifying Grant Thornton LLP as independent auditors for the fiscal year ending December 31, 2026. The record date is April 13, 2026, with 27,062,277 shares of common stock outstanding out of 60,000,000 authorized.

• ·Voting methods: Internet at www.proxypush.com/SMHI, toll-free phone 1.866.859.2198, mail proxy card, or virtually at www.proxydocs.com/SMHI.
• ·Quorum requires majority in voting power of shares entitled to vote.
• ·Proposal 1 (Directors): Plurality vote; Proposal 2 and 3: Majority of shares present.
• ·Company address: 12121 Wickchester Lane, Suite 500, Houston, TX 77079.

16-04-2026

Stellus Capital Investment Corporation's DEF 14A proxy statement for its virtual 2026 Annual Meeting on June 16, 2026, seeks stockholder approval to elect one director for a three-year term, approve a new investment advisory agreement with Stellus Capital Management, LLC (identical terms to the existing one) triggered by its pending acquisition by Ridgepost Capital, LLC (affiliate of Ridgepost with $43B AUM as of Dec 31, 2025), and approve adjournment if needed. The Board, including Independent Directors, unanimously recommends voting 'FOR' all proposals, highlighting benefits such as enhanced deal origination, investor relations, and IT resources from Ridgepost's platform without changes to management or operations. There are 28,947,255 shares of common stock outstanding as of the April 15, 2026 record date.

• ·Annual Meeting held virtually at 10:00 a.m. Central Time on June 16, 2026; registration required by 11:59 p.m. ET on June 15, 2026.
• ·Record date: April 15, 2026.
• ·Purchase Agreement for Advisor acquisition announced February 5, 2026; Company not a party.
• ·New Investment Advisory Agreement requires approval by Board (including Independent Directors) and stockholders per 1940 Act (lesser of 67% of shares present if >50% quorum or >50% of outstanding shares).
• ·Proxy materials and 10-K for year ended December 31, 2025 available at https://web.viewproxy.com/SCM/2026 and www.stelluscapital.com.